Grady said there are certain patients who may benefit more from the use of dexmedetomidine, such as those going through alcohol withdrawal. Until further studies are done, Grady added, "I'm hard-pressed to think it's worth the expense. This drug costs twice as much as lorazepam."
Read more about lorazepam and its potential side effects at the U.S. National Library of Medicine.
SOURCES: Pratik Pandharipande, M.D., department of anesthesiology and critical care, Vanderbilt University Medical Center, Nashville, Tenn.; Kevin Grady, M.D., director, pulmonary and critical care, St. John Hospital and Medical Center, and interim chief medical officer, St. John's Health System; Dec. 12, 2007, Journal of the American Medical Association